Premium
Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score
Author(s) -
Faggiano A.,
Carratù A. C.,
Guadagno E.,
Tafuto S.,
Tatangelo F.,
Riccardi F.,
Mocerino C.,
Palmieri G.,
Damiano V.,
Siciliano R.,
Leo S.,
Mauro A.,
Tozzi L. F.,
Battista C.,
De Rosa G.,
Colao A.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13381
Subject(s) - lanreotide , medicine , somatostatin , neuroendocrine tumors , octreotide , gastroenterology , oncology , acromegaly , hormone , growth hormone